Drug Type Live biotherapeutic products |
Synonyms |
Target- |
Mechanism Bacteria replacements, Gastrointestinal microbiome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization MatriSys Bioscience, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Seborrheic | Preclinical | US | MatriSys Bioscience, Inc.Startup | - |